Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Universal Corp
UVV
$1.13B
| $3.3M | ﹤0.01% |
56,000
+600
| +1% | +$31.5K |
|
1702
PBF Energy
PBF
$8.81B
| $3.3M | ﹤0.01% |
233,300
+2,100
| +0.9% | +$25.1K |
|
|
POLY
1703
DELISTED
Plantronics, Inc.
POLY
| $3.3M | ﹤0.01% |
84,800
+2,000
| +2% | +$75.1K |
|
|
PRA
1704
DELISTED
ProAssurance
PRA
| $3.3M | ﹤0.01% |
123,200
+1,200
| +1% | +$27.8K |
|
1705
Independence Realty Trust
IRT
$3.96B
| $3.29M | ﹤0.01% |
216,700
+2,000
| +0.9% | +$28.4K |
|
1706
Cal-Maine
CALM
$3.86B
| $3.28M | ﹤0.01% |
85,400
+700
| +0.8% | +$27.5K |
|
|
SWTX
1707
DELISTED
SpringWorks Therapeutics
SWTX
| $3.28M | ﹤0.01% |
44,600
+1,400
| +3% | +$110K |
|
1708
Greif
GEF
$5B
| $3.27M | ﹤0.01% |
57,400
+900
| +2% | +$46.3K |
|
1709
Pitney Bowes
PBI
$2.28B
| $3.26M | ﹤0.01% |
395,600
+4,300
| +1% | +$36.9K |
|
1710
AMC Global Media
AMCX
$485M
| $3.25M | ﹤0.01% |
61,200
+900
| +1% | +$49.2K |
|
1711
IAMGOLD
IAG
$10.3B
| $3.23M | ﹤0.01% |
1,085,900
+10,700
| +1% | +$35.4K |
|
1712
Tanger
SKT
$4.42B
| $3.23M | ﹤0.01% |
213,500
+1,700
| +0.8% | +$25.1K |
|
1713
Surgery Partners
SGRY
$2.01B
| $3.23M | ﹤0.01% |
72,900
+21,400
| +42% | +$795K |
|
|
LMNX
1714
DELISTED
Luminex Corp
LMNX
| $3.22M | ﹤0.01% |
101,000
+1,400
| +1% | +$41.5K |
|
1715
Dine Brands
DIN
$462M
| $3.21M | ﹤0.01% |
35,700
+300
| +0.8% | +$23.3K |
|
|
VRE
1716
DELISTED
Veris Residential
VRE
| $3.21M | ﹤0.01% |
207,200
+1,900
| +0.9% | +$26.8K |
|
1717
Tennant Co
TNC
$1.18B
| $3.2M | ﹤0.01% |
40,100
+400
| +1% | +$30.3K |
|
1718
Camping World
CWH
$659M
| $3.2M | ﹤0.01% |
88,000
+1,300
| +1% | +$46.2K |
|
1719
Pathward Financial
CASH
$1.78B
| $3.2M | ﹤0.01% |
70,600
| – | – |
|
1720
Heron Therapeutics
HRTX
$63.5M
| $3.2M | ﹤0.01% |
197,200
+2,000
| +1% | +$35.7K |
|
1721
Aurinia Pharmaceuticals
AUPH
$2.06B
| $3.2M | ﹤0.01% |
245,900
+1,900
| +0.8% | +$27.6K |
|
1722
AAR Corp
AIR
$5.96B
| $3.19M | ﹤0.01% |
76,700
+1,100
| +1% | +$43.4K |
|
1723
James River Group Holdings
JRVR
$199M
| $3.19M | ﹤0.01% |
69,999
+800
| +1% | +$38.3K |
|
1724
Stewart Information Services
STC
$2B
| $3.18M | ﹤0.01% |
61,100
+700
| +1% | +$35.5K |
|
1725
Beam Therapeutics
BEAM
$2.76B
| $3.18M | ﹤0.01% |
39,700
+1,400
| +4% | +$133K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.